Blueprint Medicines Corporation (BPMC): Price and Financial Metrics

BPMC POWR Grades

• Quality is the dimension where BPMC ranks best; there it ranks ahead of 41.48% of US stocks.
• The strongest trend for BPMC is in Momentum, which has been heading up over the past 177 days.
• BPMC ranks lowest in Stability; there it ranks in the 6th percentile.

BPMC Stock Summary

• Of note is the ratio of BLUEPRINT MEDICINES CORP's sales and general administrative expense to its total operating expenses; just 15.77% of US stocks have a lower such ratio.
• With a price/sales ratio of 12.78, BLUEPRINT MEDICINES CORP has a higher such ratio than 92.17% of stocks in our set.
• With a year-over-year growth in debt of 117.62%, BLUEPRINT MEDICINES CORP's debt growth rate surpasses 89.2% of about US stocks.
• Stocks that are quantitatively similar to BPMC, based on their financial statements, market capitalization, and price volatility, are DTIL, FUSN, STRO, CYCN, and CDAK.
• Visit BPMC's SEC page to see the company's official filings. To visit the company's web site, go to www.blueprintmedicines.com.

BPMC Valuation Summary

• BPMC's EV/EBIT ratio is -5.1; this is 177.27% lower than that of the median Healthcare stock.
• Over the past 96 months, BPMC's EV/EBIT ratio has gone up 5.7.

Below are key valuation metrics over time for BPMC.

BPMC Growth Metrics

The 2 year price growth rate now stands at 6.53%.
• The 4 year cash and equivalents growth rate now stands at 560.04%.
• Its 2 year net income to common stockholders growth rate is now at -75.19%.

BPMC's revenue has moved up $205,764,000 over the prior 33 months.

The table below shows BPMC's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	272.276	-394.986	-717.557
2022-06-30	230.487	-360.692	-701.635
2022-03-31	221.235	-305.601	-650.37
2021-12-31	180.08	-298.653	-644.085
2021-09-30	107.165	-309.338	-411.067
2021-06-30	828.095	408.584	340.152

BPMC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• BPMC has a Quality Grade of C, ranking ahead of 33.2% of graded US stocks.
• BPMC's asset turnover comes in at 0.067 -- ranking 297th of 682 Pharmaceutical Products stocks.
• OTLC, SGEN, and OCGN are the stocks whose asset turnover ratios are most correlated with BPMC.

The table below shows BPMC's key quality metrics over time.